Fin Trust Capital Advisors, LLC Simulations Plus, Inc. Transaction History

Fin Trust Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	SELL	$47.75 - $66.88 $50,137 - $70,224	-1,050 Reduced 31.63%	2,270 $110,000
Q2 2022 Jul 26, 2022	BUY	$40.55 - $51.76 $34,467 - $43,996	850 Added 34.41%	3,320 $201,000
Q3 2021 Nov 16, 2021	BUY	$38.45 - $55.66 $43,448 - $62,895	1,130 Added 84.33%	2,470 $98,000
Q1 2021 May 17, 2021	SELL	$60.06 - $89.52 $17,417 - $25,960	-290 Reduced 17.79%	1,340 $85,000
Q4 2020 Feb 16, 2021	SELL	$53.26 - $77.18 $31,956 - $46,308	-600 Reduced 26.91%	1,630 $117,000
Q2 2020 Sep 11, 2020	BUY	$32.91 - $59.82 $73,389 - $133,398	2,230 New	2,230 $133,000
Q2 2020 Aug 14, 2020	SELL	$32.91 - $59.82 $99,717 - $181,254	-3,030 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$26.79 - $38.99 $81,173 - $118,139	3,030 New	3,030 $106,000

176

15.2M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $636M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.